Na+-dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 778-784

  Ohashi, Rikiya ^a   Tamai, Ikumi ^a,c   Yabuuchi, Hikaru ^a   Nezu, Jun Ichi ^b   Oku, Asuka ^b   Sai, Yoshimichi ^a,c   Shimane, Miyuki ^b   Tsuji, Akira ^a,c  

^a KANAZAWA UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CATION; CEFALORIDINE; MEPYRAMINE; QUINIDINE; SODIUM ION; TETRYLAMMONIUM; VALPROIC ACID; VERAPAMIL;

ARTICLE; CATION TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; DRUG TRANSPORT; HUMAN; HUMAN CELL; KIDNEY CELL; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SODIUM TRANSPORT;

BIOLOGICAL TRANSPORT, ACTIVE; CARNITINE; CARRIER PROTEINS; CATIONS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY; MEMBRANE PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; SODIUM; STEREOISOMERISM;

EID: 0032696186     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. +-dependent carnitine transport system in Xenopus laevis oocytes. Biochem J 309:389-393.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Bremer J (1983) Carnitine - metabolism and functions. Physiol Rev 63:1420-1480.
4. Dalakas MC, Leon-Monzon ME, Bernardini I, Gahl WA and Jay CA (1994) Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol 35:482-487.
5. De Falco FA, D'Angelo E, Grimaldi G, Scafuro F, Sachez F and Caruso G (1994) Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome. Clinica Terapeutica 144:123-127.
6. Duran N, Loof NE, Ketting D and Dorland L (1990) Secondary carnitine deficiency. J Clin Chem Clin Biochem 28:359-363.
7. Fritz IB and Yue KT (1959) Effects of carnitine on acetyl-CoA oxidation by heart muscle mitochondria Am J Physiol 197:297-304.
8. Gerber N, Dickinson GR, Harland RC, Lynn RK, Houghton D, Antonias JI and Schmiachock JC (1979) Reye-like syndrome associated with valproic acid therapy. J Pediatr 95:143-144.
9. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Buschh AE and Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.
10. Harik SI and Hritz MA (1993) Effect of acetyl-L-carnitine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Biochem Pharmacol 45:2170-2172.
11. Hashimoto N, Suzuki F, Tamai I, Nikaido H, Kuwajima M, Hayakawa J and Tsuji A (1998) Gene-dose effect on carnitine transport activity in embryonic fibroblasts of jvs mice as a model of human carnitine transporter deficiency. Biochem Pharmacol 55:1729-1732.
12. Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B and Jodal U (1998) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2:469-472.
13. Horiuchi M, Kobayashi K, Yamaguchi S, Shimizu N, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M and Saheki T (1994) Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim Biophys Acta 1226:25-30.
14. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M and Saheki T (1993) Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326:267-271.
15. Koepsell H (1998) Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 60:243-266.
16. Koizumi T, Nikaido H, Hayakawa J, Nonomura A and Yoneda T (1988) Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2° strain of mouse with similarities to Reye's syndrome. Lab Anim 22:83-87.
17. Kuntzer T, Reichmann H, Bogousslavsky J and Regli F (1990) Emetine-induced myopathy and carnitine deficiency. J Neuro 237:495-496.
18. Kuwajima M, Kono N, Horiuchi M, Imamura Y, Ono A, Inui Y, Kawata S, Hayakawa J, Saheki T and Tarui S (1991) Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun 174:1090-1994.
19. Kuwajima M, Lu K, Harashima H, Ono A, Sato I, Mizuno A, Murakami T, Nakajima H, Miyagawa J, Namba M, Hanafusa T, Hayakawa J, Matsuzawa Y and Shima K (1996) Carnitine transport defect in fibroblasts of juvenile visceral steatosis (jvs) mouse. Biochem Biophys Res Commun 223:283-287.
20. Matsuoka M and Igisu H (1993) Comparison of the effects of L-carnitine, D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia. Biochem Pharmacol 46: 159-164.
21. Molstad P, Bohmer T and Eiklid K (1977) Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim Biophys Acta 471:296-304.
22. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matauishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M and Tsuji A (1999) Primary systemic cartinine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
23. Ohtani Y, Endo F and Matsuda I (1982) Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101:782-785.
24. Pettegrew JW, Hunk WE, Panchalingam K, Kanfere JN and McClure RJ (1995) Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 16:1-4.
25. Pons R and De Vivo DC (1995) Primary and secondary carnitine deficiency syndromes. J Child Neurol 10:2S8-2S24.
26. Prasad PD, Huang W, Ramamoothy S, Carter AL, Leibach FH and Ganapathy V (1996) Sodium-dependent carnitine transport in human placental choriocarcinoma cells. Biochim Biophys Acta 1284:109-117.
27. Rai G, Wright G, Scott L, Beston B, Rest J and Exton-Smith AN (1990) Double-blind, placebo controlled study of acetyl-L-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin 11:638-647.
28. Scholte HR, Pereira RR, De Jonge PC, Luyt-Houwen IEM, Verduin MHM and Ross JD (1990) Primary carnitine deficiency. J Clin Chem Clin Biochem 28:351-357.
29. Siliprandi N, Di Lisa F, Menabo R, Ciman M and Sartorelli L (1990) Transport and functions of carnitine in muscles. J Clin Chem Clin Biochem 28:303-306.
30. Steffen V, Santiago M, De La Cruz CP, Revilla E, Machado A and Cano J (1995) Effect of intraventricular injection of 1-methyl-4-phenylpyridinium: Protection by acetyl-L-carnitine. Hum Exp Toxcol 14:865-871.
31. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y and Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Bid Chem 273:20378-20382.
32. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M and Tsuji A (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111.
33. Tein I, DiMauro S, Xie ZW and De Vivo DC (1996) Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency. Pediatr Res 34:281-287.
34. Tein I and Xie ZW (1994) Reversal of valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts. Kochern Biophys Res Commun 204:753-758.
35. Tune BM and Hsu C-Y (1994) Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: Structure-activity relationships. J Pharmacol Exp Ther 270:873-880.
36. Wu X, Prasad PD, Leibach FH and Ganapathy V (1998) cDNA sequence, transport function, and genomic organization of human OCTK2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595.
37. Zhang L, Brett CM and Giacomini KM (1998) Role of organic cation transporters in drug absorption and elimination. Anna Rev Pharmacol Toxicol 38:431-460.
38. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S and Giacomini KM (1997) Cloning and functional expression of human liver organic cation transporter. Mol Pharmacol 51:913-921.